Range
93.49 - 97.19
Vol / Avg.
3M/670.8K
Div / Yield
-
52 Wk
57.66 - 106.57
Mkt Cap
6.2B
Payout Ratio
-
Open
94.5
P/E
-
EPS
-4.27
Shares
65.1M
Outstanding
65.1M
Total Float
57.7M
Benzinga - May 27, 2021, 4:17PM
load more
Sector: Health Care.Industry: Biotechnology
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-2.820-2.970 -0.1500
REV40.630M43.823M3.193M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BHVNBiohaven Pharma Hldgs0.76%6.2B

Biohaven Pharma Hldgs Frequently Asked Questions

Q

How do I buy Biohaven Pharma Hldgs (BHVN) stock?

A

You can purchase shares of Biohaven Pharma Hldgs (NYSE: BHVN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Biohaven Pharma Hldgs's (BHVN) competitors?

Q

What is the target price for Biohaven Pharma Hldgs (BHVN) stock?

A

The latest price target for Biohaven Pharma Hldgs (NYSE: BHVN) was reported by Cantor Fitzgerald on June 1, 2021. The analyst firm set a price target for 140.00 expecting BHVN to rise to within 12 months (a possible 47.38% upside). 16 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biohaven Pharma Hldgs (BHVN)?

A

The stock price for Biohaven Pharma Hldgs (NYSE: BHVN) is $94.99 last updated Fri Jun 18 2021 19:59:58 GMT+0000 (Coordinated Universal Time).

Q

Does Biohaven Pharma Hldgs (BHVN) pay a dividend?

A

There are no upcoming dividends for Biohaven Pharma Hldgs.

Q

When is Biohaven Pharma Hldgs (NYSE:BHVN) reporting earnings?

A
Biohaven Pharma Hldgs’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Biohaven Pharma Hldgs (BHVN) going to split?

A

There is no upcoming split for Biohaven Pharma Hldgs.

Q

What sector and industry does Biohaven Pharma Hldgs (BHVN) operate in?

A

Biohaven Pharma Hldgs is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NYSE.